Viatris Q2 revenue rises 5% to $3.8 billion; GAAP net loss $119 million; raises 2026 guidance
Viatris reported second-quarter 2026 results with total revenues of $3.8 billion, up 5% on a reported basis, and adjusted EBITDA of $1.2 billion, up 10%. A U.S. GAAP net loss of $119 million was driven mainly by a non-cash charge of $177.8 million tied to the planned sale of Tyrvaya product rights, and the company raised the midpoints of its 2026 guidance for all metrics.
Key points
- Total revenues $3.8 billion, up 5% reported and 3.5% operationally versus second-quarter 2025; adjusted EPS $0.69, up 11% reported
- U.S. GAAP net loss $119 million, or $(0.10) per share, versus a net loss of $5 million a year earlier, mainly from a $177.8 million non-cash Tyrvaya charge
- 2026 guidance midpoints raised: total revenues to $14.75 billion from $14.70 billion, adjusted EBITDA to $4.4 billion from $4.3 billion, adjusted EPS to $2.52 from $2.40
- Returned approximately $550 million to shareholders through August 5, 2026, including about $270 million in share repurchases; about $730 million remains under the buyback program
The filing
Written by AI on Nov 8, 2026, 12:42 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 06, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.